Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Antignani

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
ASAIO Transactions|July 1, 1989
Fall of cholesterol with time on dialysis: impact on atherogenicityM Lapuz, M M Avram, A Lustig, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Variability of peritoneal clearances for apolipoprotein and its relationship to susceptibility for atherosclerotic changes in CAPDP A Fein, D Fletcher, A Antignani, et al.
American Journal of Nephrology|January 1, 1990
Urinary red cell size: diagnostic value and determinantsP Goldwasser, A Antignani, N Mittman, et al.
European Journal of Biochemistry|December 22, 1999
NADP+-dependent glutamate dehydrogenase in the Antarctic psychrotolerant bacterium Psychrobacter sp. TAD1. Characterization, protein and DNA sequence, and relationship to other glutamate dehydrogenasesR Di Fraia, V Wilquet, M A Ciardiello, et al.
Cell Death and Differentiation|September 23, 2008
p47phox-deficient immune microenvironment signals dysregulate naive T-cell apoptosisM Donaldson, A Antignani, J Milner, et al.
New York State Journal of Medicine|May 1, 1991
Lipid abnormalities in black renal patientsD E Burrell, A Antignani, P Goldwasser, et al.
ASAIO Transactions|July 1, 1988
Lipids in diabetic and nondiabetic hemodialysis and CAPD patientsM M Avram, A Antignani, P Goldwasser, et al.
The American Journal of Medicine|November 1, 1989
Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysisM M Avram, P A Fein, A Antignani, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
ASAIO Transactions|July 1, 1989
Fall of cholesterol with time on dialysis: impact on atherogenicityM Lapuz, M M Avram, A Lustig, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1989
Variability of peritoneal clearances for apolipoprotein and its relationship to susceptibility for atherosclerotic changes in CAPDP A Fein, D Fletcher, A Antignani, et al.
American Journal of Nephrology|January 1, 1990
Urinary red cell size: diagnostic value and determinantsP Goldwasser, A Antignani, N Mittman, et al.
European Journal of Biochemistry|December 22, 1999
NADP+-dependent glutamate dehydrogenase in the Antarctic psychrotolerant bacterium Psychrobacter sp. TAD1. Characterization, protein and DNA sequence, and relationship to other glutamate dehydrogenasesR Di Fraia, V Wilquet, M A Ciardiello, et al.
Cell Death and Differentiation|September 23, 2008
p47phox-deficient immune microenvironment signals dysregulate naive T-cell apoptosisM Donaldson, A Antignani, J Milner, et al.
New York State Journal of Medicine|May 1, 1991
Lipid abnormalities in black renal patientsD E Burrell, A Antignani, P Goldwasser, et al.
ASAIO Transactions|July 1, 1988
Lipids in diabetic and nondiabetic hemodialysis and CAPD patientsM M Avram, A Antignani, P Goldwasser, et al.
The American Journal of Medicine|November 1, 1989
Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysisM M Avram, P A Fein, A Antignani, et al.
Pageof 2